A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer
Clinical trial NCT01630733 · COMPLETED
Trial details
- NCT number
- NCT01630733
- Sponsor
- Achieve Life Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-24
- Primary completion
- 2016-11-17
- Enrollment
- 664
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.